Biofidelity launches Aspyre® Lung Reagents, now enabling integrated tissue and liquid biopsy analysis
recent articles
Nijmegen, the Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a distribution collaboration with Paige, a global leader in AI-based...
Corista: DP3’s momentum as a world-class integrated pathology solution grows Concord, MA (Feb. 7, 2024) – Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License...
From Aiosyn blog: Diana Rosentul, a Regulatory Affairs Specialist at Aiosyn, intricately manages the regulatory landscape associated with the integration of AI-based solutions within clinical and research institutions. Drawing upon her...
Qritive Secures Multi-Year Contracts to Drive AI Adoption in Pathology Across India MUMBAI, India & SINGAPORE--(BUSINESS WIRE)--QritiveTM, a leading provider of AI solutions for pathology labs worldwide, announces partnership with...
ArteraAI: The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based...
Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...
